Brightsurf Science News & Current Events

September 25, 2005
Psychologists find more sensitive tests for predicting Alzheimer's as well as changes in cognition
Two recent studies may help clinicians and researchers better predict and understand dementia of the Alzheimer's type early in its history.

'Healthy weight, healthy shape' key in preventing heart disease
Playing an increasingly important role in the prevention of cardiovascular disease (CVD), controlling one's weight through healthy eating and regular exercise can directly reduce the risk of heart disease and also the impact of an existing heart condition.

Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease
Neurologix's 12-patient Phase I trial showed positive results in patients with Parkinson's disease.

Defect in gene causes 'neuralgic amyotrophy'
Neuralgic Amyotrophy is a painful disorder of the peripheral nervous system.

Hebrew University receives its largest NIH research grant ever -- $5.6 million biodefense award
A research grant of $5.6 million in the field of biodefense has been awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), to a Hebrew University of Jerusalem researcher for the development of a broadly effective drug against a family of toxins called superantigens.

Left handedness may be linked to increased risk of breast cancer
Left handedness may be linked to an increased risk of breast cancer, finds new research published online by the BMJ today.

Desert pathfinder at work
The Atacama Pathfinder Experiment (APEX) project celebrates the inauguration of its outstanding 12-m telescope, located on the 5100 m high Chajnantor plateau in the Atacama Desert (Chile).

Human beta-cell line offers hope for type 1 diabetes breakthrough
Scientists at Rosalind Franklin University of Medicine and Science, with international colleagues, succeed in creating reversibly immortalized human beta-cells, with eye toward establishing universal cells for treatment of type 1 diabetes. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to